Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0Y6X stock hub

LON/0Y6X has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0Y6Xis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

71.7B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0Y6X

In the news

Latest news · LON/0Y6X

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13

P25 12.9P50 16.9P75 23.5

Trailing P/E21.1

P25 15.9P50 22.9P75 35.8

ROE9.4

P25 -54.2P50 2.1P75 13.7

ROIC8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0Y6X market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Ireland
Country code	UK
Employees	95,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$86.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	IE00BTN1Y115
Last refreshed	2026-05-10
Market cap	$71.7B
Price	$76.95
Price currency	USD
Rev Per Employee	275,161.61x
Sector	Healthcare
Sic	3845
Symbol	lon/0Y6X
Website	https://www.medtronic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.74%
EV Earnings	25.38x
EV/EBIT	17.73x
EV/EBITDA	12.07x
EV/FCF	21.64x
EV/Sales	3.31x
FCF yield	5.55%
Forward P/E	13.02x
P/B ratio	1.98x
P/E ratio	21.11x
P/S ratio	2.74x
PE Ratio10 Y	31x
PE Ratio3 Y	27.1x
PE Ratio5 Y	29.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.68%
EBITDA Margin	26.6%
FCF margin	15.25%
Gross margin	65.16%
Gross Profit	$17B
Gross Profit Growth	6.18%
Gross Profit Growth Q	5.95%
Gross Profit Growth3 Y	4.04%
Gross Profit Growth5 Y	5.18%
Net Income	$3.4B
Net Income Growth	8.29%
Net Income Growth Q	-11.67%
Net Income Growth Years	1%
Net Income Growth3 Y	4.31%
Net Income Growth5 Y	9.79%
Pretax Margin	15.67%
Profit Margin	13%
Profit Per Employee	$35,772
Profitable Years	40
ROA	4.57
Roa5y	4.21
ROCE	8.09
ROE	9.39
Roe5y	8.16
ROIC	7.98
Roic5y	7.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.65%
Cagr3y	-1.95%
Cagr5y	-6.75%
Div CAGR10	7.58%
Div CAGR3	-2.45%
Div CAGR5	3.44%
EPS Growth	9.47
EPS Growth Q	-11.8
EPS Growth Years	1
EPS Growth3 Y	5.55
EPS Growth5 Y	10.95
FCF Growth	-1.04%
FCF Growth Q	9.73%
FCF Growth3 Y	9.1%
FCF Growth5 Y	3.16%
OCF Growth	-0.11%
OCF Growth Q	6.69%
OCF Growth10 Y	2.3%
OCF Growth3 Y	8.93%
OCF Growth5 Y	4.15%
Revenue Growth	6.88x
Revenue Growth Q	8.74x
Revenue Growth Quarters	12x
Revenue Growth Years	2x
Revenue Growth3 Y	4.86x
Revenue Growth5 Y	4.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.39
Assets	$67.4B
Cash	$6.2B
Current Assets	$17.7B
Current Liabilities	$7B
Debt	$20.7B
Debt EBITDA	$2.88
Debt Equity	$0.57
Debt FCF	$5.19
Equity	$36.2B
Interest Coverage	9.3
Liabilities	$31.2B
Long Term Assets	$49.7B
Long Term Liabilities	$24.2B
Net Cash	$-14.4B
Net Cash By Market Cap	$-20.07
Net Debt EBITDA	$2.07
Net Debt Equity	$0.4
Net Debt FCF	$3.61
Tangible Book Value	$-2.4B
Tangible Book Value Per Share	$-1.86
WACC	6.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.54
Inventory Turnover	2.07
Net Working Capital	$4.7B
Quick ratio	1.55
Working Capital	$10.7B
Working Capital Turnover	$2.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.83%
Dividend Growth	-2.99%
Dividend Growth Years	0%
Dividend per share	$2.11
Dividend Years	13
Dividend Yield	2.74%
Ex Div Date	2026-03-27
Last Dividend	$0.53
Payout Frequency	Quarterly
Payout Ratio	78.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.65%
200-day SMA	93.86
3Y total return	-5.73%
50-day SMA	86.61
50-day SMA vs 200-day SMA	50under200
5Y total return	-29.47%
All Time High	135.8
All Time High Change	-43.35%
All Time High Date	2021-09-09
All Time Low	68.87
All Time Low Change	11.73%
All Time Low Date	2023-10-30
ATR	2.42
Beta	0.63
Ch YTD	-20.35
High	78.87
High52	106.7
High52 Date	2025-11-26
High52ch	-27.85%
Low	76.7
Low52	76.7
Low52 Date	2026-05-08
Low52ch	0.28%
Ma50ch	-11.15%
Price vs 200-day SMA	-18.02%
RSI	23.79
RSI Monthly	41.04
RSI Weekly	25.75
Sharpe ratio	-0.36x
Sortino ratio	-0.23
Total Return	3.57%
Tr YTD	-19.71
Tr1m	-11.26%
Tr1w	-4.42%
Tr3m	-24.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$4.9B
Operating Income Growth	-1.3
Operating Income Growth Q	-0.88
Operating Income Growth3 Y	4.42
Operating Income Growth5 Y	11.22
Operating margin	18.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,281,569,053%
Net Borrowing	-740,849,140
Shares Insiders	0.04%
Shares Institutions	87.89%
Shares Qo Q	0.12%
Shares Yo Y	-0.83%
Short Ratio	1.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3.7B
Average Volume	4,588.6x
Bv Per Share	28.12
CAPEX	$-1.4B
Ch1m	-11.26
Ch1w	-4.42
Ch1y	-7.58
Ch3m	-24.8
Ch3y	-14.49
Ch5y	-39.45
Ch6m	-16.25
Change	-1.05%
Change From Open	-1.7
Close	77.77
Days Gap	0.66
Depreciation Amortization	2,061,174,340
Dollar Volume	200,377.8
Earnings Date	2026-06-03
EBIT	$4.9B
EBITDA	$7B
EPS	$2.64
F Score	6
FCF	$4B
FCF EV Yield	4.62x
Financing CF	-3,835,156,080
Fiscal Year End	April
Founded	1,949
Goodwill	30,728,368,488
Graham Number	56.45655
Graham Upside	-26.63
Income Tax	$680M
Investing CF	-1,846,856,760
Is Primary Listing	0
Last Earnings Date	2026-02-17
Last Report Date	2026-01-23
Lynch Fair Value	$35.68
Lynch Upside	-53.64
Ma150	94.25
Ma150ch	-18.36%
Ma20	82.33
Ma20ch	-6.53%
Net CF	-68,511,240
Next Earnings Date	2026-06-03
Open	78.28
P FCF Ratio	18
P OCF Ratio	13.37
Payment Date	2026-04-17
Position In Range	11.52
Ppne	5,265,897,006
Price Date	2026-05-08
Price EBITDA	$10.32
Relative Volume	0.58x
Revenue	26,140,353,120x
SBC By Revenue	1.27x
Share Based Comp	332,242,680
Tax By Revenue	2.6x
Tax Rate	16.59%
Tr6m	-14.95%
Volume	2,604
Z Score	2.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0Y6X dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$2.11 annual per share

Payout ratio

+78.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.4%

0 consecutive years of growth

Total shareholder yield

+3.6%

Next ex-dividend date: 2026-03-27

Performance

LON/0Y6X stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0Y6X?

Insider, institutional, and short-interest positioning.

Institutional ownership

+87.9%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0Y6X momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

23.8

Below 30: short-term oversold

Price vs 200-day MA

-18.0%

50/200-day relationship not available

Beta (5Y)

0.63

Less volatile than the market

Sharpe ratio

-0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0Y6X

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0Y6X stock rating?

lon/0Y6X is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0Y6X analysis?

The full report lives at /stocks/lon/0Y6X/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0Y6X?

The latest report frames lon/0Y6X around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0Y6X page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.